XM does not provide services to residents of the United States of America.
S
S

Subsea

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

AstraZeneca, Danske Bank, Johnson Matthey

EUROPE RESEARCH ROUNDUP-AstraZeneca, Danske Bank, Johnson Matthey Oct 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AstraZeneca, Danske Bank and Johnson Matthey, on Thursday. HIGHLIGHTS * AstraZeneca AZN.L : Jefferies cuts target price to 11,400p from 11,700p * Baltic Classifieds Group Plc BCG.L : Berenberg raises target price to 360p from 300p * Danske Bank DANSKE.CO : JP Morgan cuts target price to DKK 185 from DKK 190 * John
A
B
D
G
K
N
P
P
R
R
S
S
T
V
V
J
N
P

European oil stocks fall tracking lower oil prices

BUZZ-European oil stocks fall tracking lower oil prices ** Shares in European oil companies move lower, tracking oil prices , which fell on prospects of Saudi Arabia raising output ** Saudi Arabia is preparing to abandon its unofficial price target of $100 a barrel for crude as it prepares to increase output, the Financial Times reported ** "Moment
B
E
E
S
G

BNP sees growing challenges for oil sector, downgrades Subsea 7

BUZZ-BNP sees growing challenges for oil sector, downgrades Subsea 7 ** Exane BNP Paribas warns of the impact of peaking demand, increasing supply and the return of spare capacity from OPEC+ on the oil sector, as it cites the latest medium-term outlook from the International Energy Agency ** OPEC+ plans to gradually increase oil production by 2.2 m
S
S
S

Top of the Street: European luxury, beverages; Nestle, Kion, Subsea 7

BUZZ-Top of the Street: European luxury, beverages; Nestle, Kion, Subsea 7 A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Barclays downgrades Burberry BRBY.L and Gucci owner Kering PRTP.PA to "underweight" from "equal weight" as it expects the weakness in the China market to affect the luxury groups in a long term ** Barclays cuts Nestle NESN.S to "equal weight" from "overweight" saying a near-term recovery is unlikely for the Swiss chocolate maker ** C
B
C
K
N
R
S
P

Accelleron, BHP, Kingfisher

EUROPE RESEARCH ROUNDUP-Accelleron, BHP, Kingfisher Aug 28 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Accelleron, BHP and Kingfisher, on Wednesday. HIGHLIGHTS * Accelleron ACLN.S : Deutsche Bank raises target price to CHF 42 from CHF 34 * BHP Group BHPB.L : JP Morgan cuts target price to 2,580p from 2,650p * Kingfisher KGF.L : Citigroup cuts to neutral from buy * Vonovia SE VNAn.DE : Citigroup raises target price to EUR 52.80 f
A
A
A
B
B
B
C
C
D
E
I
K
N
P
S
S
S
S
T
V
H
B
D

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.